Brii Biosciences Limited (7SS) — Net Asset Quality Index
Brii Biosciences Limited (7SS) has a Net Asset Quality Index of 98.5% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €2.36 Billion minus total liabilities of €36.20 Million yields net assets of €2.32 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read Brii Biosciences Limited (7SS) financial obligations for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Brii Biosciences Limited Net Asset Quality Index Over Time (2020–2025)
This chart shows how Brii Biosciences Limited's Net Asset Quality Index has evolved across 6 annual periods from 2020 to 2025. As of December 2025, the index stands at 98.5%, representing net assets of €2.32 Billion against total assets of €2.36 Billion EUR. For live market cap and overall valuation, see 7SS company net worth.
Annual Net Asset Quality Index for Brii Biosciences Limited (2020–2025)
The table below presents the year-by-year Net Asset Quality Index for Brii Biosciences Limited from 2020 to 2025, covering 6 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See Brii Biosciences Limited shareholders equity for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 98.5% | €2.32 Billion | €2.36 Billion | €36.20 Million | ▲ +2.2 pp |
| 2024 | 96.3% | €2.61 Billion | €2.71 Billion | €100.55 Million | ▲ +0.2 pp |
| 2023 | 96.1% | €3.07 Billion | €3.20 Billion | €125.87 Million | ▲ +3.0 pp |
| 2022 | 93.1% | €3.16 Billion | €3.39 Billion | €234.35 Million | ▲ +1.4 pp |
| 2021 | 91.7% | €3.31 Billion | €3.61 Billion | €300.44 Million | ▲ +229.1 pp |
| 2020 | -137.4% | €-1.74 Billion | €1.27 Billion | €3.01 Billion | — |